FDA
approval
· 2026-01-30
FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved Teva's supplemental application for a generic fixed-dose combination of olanzapine and fluoxetine, expanding access to this antidepressant/antipsyc…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLANZAPINE AND FLUOXETINE (OLANZAPINE AND FLUOXETINE)